The product Nandrolone Decanoate 250 mg/mL, manufactured by Optitropin, underwent independent testing to verify its potency. The sample was submitted by B Ware, an individual consumer with no commercial affiliations, and analyzed by Janoshik Analytical. The results confirmed a measured concentration of 257.48 mg/mL, which is 102.99% of the labeled claim, indicating a slight overdose.
Testing was initiated on 30 August 2024, with the sample received on 4 September 2024, and analysis completed on 6 September 2024. The findings confirm that the tested batch slightly exceeds its labeled dosage, reflecting consistent manufacturing standards.
This report is published to support harm reduction, transparency, and informed consumer decision-making.
Detailed Report
Product Overview
- Manufacturer: Optitropin
- Product Name: Nandrolone Decanoate
- Active Ingredient: Nandrolone Decanoate
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #48456
- Testing Ordered: 30 August 2024
- Sample Received: 4 September 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: B Ware (Individual)
- Analysis Paid For By: B Ware (Individual)
Testing Results
| Specification | Measured Concentration | Accuracy | Variance |
|---|---|---|---|
| 250 mg/mL (as per label) | 257.48 mg/mL | 102.99% | +2.99% |
Verification Details
- Verification URL: https://janoshik.com/tests/48456_WRZ3K5FYGLUK
Evaluation of Consumer-Submitted Testing
The results confirm that the Nandrolone Decanoate (250 mg/mL) sample slightly exceeds its labeled claim, with a measured concentration of 257.48 mg/mL (2.99% above the label claim). This variance is within acceptable pharmaceutical limits, reflecting high-quality manufacturing consistency.
Since this sample was submitted by B Ware, an individual with no ties to resellers, manufacturers, or distributors, the test results are more reliable compared to reseller-funded testing, which may selectively provide high-quality batches. However, as always, additional independent testing of multiple batches is recommended to verify long-term product consistency.
Conclusion
The analysis of Optitropin’s Nandrolone Decanoate 250 mg/mL confirms its potency, with a slightly higher-than-labeled concentration of 257.48 mg/mL. While the product meets expectations in terms of quality, continued third-party verification across multiple batches is advised to ensure consistency.
This report is published to support harm reduction efforts, providing consumers with transparent data to make informed choices regarding anabolic steroid products.
Disclaimer
This report is for educational and harm reduction purposes only. The results pertain solely to the batch tested and may not reflect the quality of other batches. Since this product was tested independently by an individual consumer with no commercial interest, the findings are less likely to be biased. However, readers are encouraged to critically assess these results alongside additional third-party testing. Always consult healthcare professionals and adhere to local regulations before using such products.
